Key result
Electrical cardioversion was safely applied in two pregnant women with supraventricular arrhythmias, highlighting it as a viable treatment when supported by fetal monitoring and emergency delivery facilities.
Why the study?
Does electrical cardioversion safely and effectively treat sustained symptomatic supraventricular arrhythmias in pregnant women?
Case Report (n=2)
Does electrical cardioversion safely and effectively treat sustained symptomatic supraventricular arrhythmias in pregnant women?
Electrical cardioversion is a safe and effective treatment for maternal tachycardia in pregnancy, provided continuous fetal monitoring and emergency caesarean section facilities are available.
Supports monitored electrical cardioversion in select pregnant patients; leaves open need for prospective data before wider adoption.
Two pregnant patients with a sustained symptomatic maternal supraventricular arrhythmia are presented. Both patients were treated with direct-current cardioversion. Electrical cardioversion during pregnancy is a rarely applied but highly effective procedure in the treatment of maternal cardiac arrhythmias and is assumed safe for both mother and child. However, once foetal viability is reached, monitoring of the foetal heart rate is advised and facilities for immediate caesarean section should be available.
No takes yet. Share an insight, caveat, or question.
Tromp et al. (2011) conducted a case report in Sustained symptomatic maternal supraventricular arrhythmia during pregnancy (n=2). Electrical cardioversion was evaluated on Maternal and fetal safety and arrhythmia termination. Electrical cardioversion was safely applied in two pregnant women with supraventricular arrhythmias, highlighting it as a viable treatment when supported by fetal monitoring and emergency delivery facilities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: